17.8K
Articles
1.3M
Citations
5.5
avg. Impact Factor
461
h-index

Most Cited Articles of Department of Medical Oncology in 2017

TitleJournalYearCitations
Computational Radiomics System to Decode the Radiographic PhenotypeCancer Research20171.6K
An immunogenic personal neoantigen vaccine for patients with melanomaNature20171.4K
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitorsScience20171.2K
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trialLancet, The20171.2K
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 ProfilesCell20171.1K
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 MutationNew England Journal of Medicine20171.1K
iRECIST: guidelines for response criteria for use in trials testing immunotherapeuticsLancet Oncology, The20171K
Integrated genomic characterization of oesophageal carcinomaNature2017965
Comprehensive Molecular Characterization of Muscle-Invasive Bladder CancerCell2017961
Tumor and Microenvironment Evolution during Immunotherapy with NivolumabCell2017831
A single-cell survey of the small intestinal epitheliumNature2017676
Systemic Therapy for Metastatic Renal-Cell CarcinomaNew England Journal of Medicine2017641
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayNature2017620
CDK4/6 inhibition triggers anti-tumour immunityNature2017618
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017Annals of Oncology2017586
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineScience2017577
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy targetNature2017510
Monitoring immune-checkpoint blockade: response evaluation and biomarker developmentNature Reviews Clinical Oncology2017498
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistanceScience2017492
Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependentScience2017486
Multiple myelomaNature Reviews Disease Primers2017484
YY1 Is a Structural Regulator of Enhancer-Promoter LoopsCell2017444
Census and evaluation of p53 target genesOncogene2017427
Resistance to checkpoint blockade therapy through inactivation of antigen presentationNature Communications2017409
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal MelanomaCancer Cell2017391